FDA COVID-19 EUA Resources

Apr 14, 2020

3D rendered illustration of the COVID-19 virus with detailed spike proteins on a blue background with other similar germs in the distance.
3D rendered illustration of the COVID-19 virus with detailed spike proteins on a blue background with other similar germs in the distance.

Introduction

ClariMed presented on the EUA process this morning. To see the slides, please follow this link.

ClariMed recommended joining the next FDA town hall – meeting information is listed at the end of this post. 

ClariMed also mentioned that N95Decon.org is working to empower hospitals to safely re-use N95 masks to battle COVID-19 based on CDC guidelines

Here are the authorizations for the formally authorized products for facilitating the re-use of N95 masks:
https://www.fda.gov/media/136529/download
https://www.fda.gov/media/136843/download
https://www.fda.gov/media/136884/download

FDA COVID-19 Town Halls: COVID-19 Diagnostic Test Kits

Since April 1, 2020, the U.S. Food and Drug Administration (FDA) has hosted virtual town hall sessions each Wednesday to discuss the development and use of COVID-19 Diagnostic Test Kits.

Other FDA COVID-19 Webinars

FDA hosts webinars regarding topics beyond COVID-19 in-vitro diagnostic test kits. On April 6, 2020, the agency hosted a webinar for device manufacturers and industry to discuss and answer questions on the two recently issued, immediately-in-effect guidances on enforcement policy for PPE during COVID-19:

  • Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised) (April 2, 2020)

  • Enforcement Policy for Gowns, Other Apparel, and Gloves During the Coronavirus Disease (COVID-19) Public Health Emergency (March 30, 2020)

To view the slides and read the transcript, please follow these links.

The Next FDA Town Hall: Wednesday, April 15, 2020

The next FDA Town Hall occurs tomorrow, Wednesday, April 15, 2020 – there is no need to register. Please see the quoted meeting information, below:

“On April 1, 2020, from 12:15 pm – 1:15 pm Eastern Time, the U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for SAR-CoV-2. The purpose of this Town Hall is to help answer technical questions about the development and validation of tests for SARS-CoV-2 and the recently issued guidance.
More Info: https://www.fda.gov/medical-devices/workshops-conferences-medical-devices/virtual-town-hall-series-immediately-effect-guidance-coronavirus-covid-19-diagnostic-tests-04012020?utm_campaign=2020-03-27%20April%201-%20Virtual%20Town%20Hall%20COVID-19&utm_medium=email&utm_source=Eloqua

“Registration is not necessary.
Date: Multiple Dates (please see above) Time: 12:15 p.m. – 1:15 p.m. To ensure you are connected, please dial in 15 minutes prior to the start of the call. U.S. Callers Dial:

  • 888-233-1204

  • Conference Number: RWXW1175579

  • Passcode: 6110103

Let's work together!

We’re always looking for new opportunities. If you would like to partner with us, please get in touch.

Let's work together!

We’re always looking for new opportunities. If you would like to partner with us, please get in touch.

Let's work together!

We’re always looking for new opportunities. If you would like to partner with us, please get in touch.